Xponance’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23,548
Closed -$1.29M 1224
2022
Q2
$1.29M Buy
23,548
+8,842
+60% +$478K 0.03% 505
2022
Q1
$716K Sell
14,706
-174
-1% -$7.78K 0.01% 733
2021
Q4
$621K Sell
14,880
-954
-6% -$40K 0.01% 816
2021
Q3
$674K Sell
15,834
-618
-4% -$27.8K 0.01% 747
2021
Q2
$817K Buy
16,452
+1,915
+13% +$101K 0.02% 687
2021
Q1
$786K Buy
14,537
+283
+2% +$14.7K 0.02% 569
2020
Q4
$739K Sell
14,254
-64
-0.4% -$3.04K 0.02% 578
2020
Q3
$624K Buy
14,318
+1,841
+15% +$81.8K 0.02% 563
2020
Q2
$517K Buy
+12,477
New +$480K 0.01% 594

Other funds holding CDK

Xponance's CDK Position: Q3 2022 in Review

Xponance sold out of CDK Global, Inc. (CDK) in Q3 2022, closing a stake of 23,548 shares — an estimated $1.29M sold.

Xponance first reported a position in CDK in Q2 2020 and held it in 9 quarters. The position peaked at $1.29M in Q2 2022. 6 funds tracked by Wall St. Rank hold CDK as of Q3 2022.

  • Xponance reported no remaining CDK Global, Inc. position as of Q3 2022 after selling out during the quarter.
  • Xponance sold 23,548 CDK Global, Inc. shares in Q3 2022, an estimated $1.29M.
  • Xponance first reported a position in CDK Global, Inc. in Q2 2020 and held it in 9 quarters.
  • Xponance's CDK Global, Inc. position peaked at $1.29M in Q2 2022.
  • 6 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2022.

Based on Xponance's 13F filing for Q3 2022, filed 24 Oct 2022.